RecruitingNCT07685873

Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease

Sponsor

Tianjin Medical University

Enrollment

200 participants

Start Date

Jun 25, 2026

Study Type

OBSERVATIONAL

Conditions

Parkinson Disease Parkinson's Disease and Parkinsonism Parkinson Disease Dementia

Summary

To evaluate the potential usefulness of 18F-FPyCO/SMBT-1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various MAO-B-related disease patients.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Diagnostic Test: 18F-FPyCO/SMBT-1 for people with parkinson disease, parkinson disease dementia, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.